Daniel J. Weiner

Daniel J. Weiner

Auto-generated profile, based on publicly available information

Daniel J. Weiner

University of Pittsburgh School of Medicine Department of Pediatrics, Division of Pulmonology Pittsburgh, PA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
BCBruce H. Culver
Bruce H. Culver
BGBrian L. Graham
Brian L. Graham
ACAllan L. Coates
Allan L. Coates
JWJack Wanger
Jack Wanger
CBCristine E. Berry
Cristine E. Berry
DWDaniel J. Weiner
Daniel J. Weiner
Background: The American Thoracic Society committee on Proficiency Standards for Pulmonary Function Laboratories has recognized the need for a standardized reporting format for pulmonary function tests. Although prior documents have offered guidance on the reporting of test data, there is considerable variability in how these results are presented to end users, leading to potential confusion and miscommunication. Methods: A project task force, consisting of the committee as a whole, was approved to develop a new Technical Standard on reporting pulmonary function test results. Three working groups addressed the presentation format, the reference data supporting interpretation of results, and a system for grading quality of test efforts. Each group reviewed relevant literature and wrote drafts that were merged into the final document. Results: This document presents a reporting format in test-specific units for spirometry, lung volumes, and diffusing capacity that can be assembled into a report appropriate for a laboratory’s practice. Recommended reference sources are updated with data for spirometry and diffusing capacity published since prior documents. A grading system is presented to encourage uniformity in the important function of test quality assessment. Conclusions: The committee believes that wide adoption of these formats and their underlying principles by equipment manufacturers and pulmonary function laboratories can improve the interpretation, communication, and understanding of test results.

1 February 2017 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
EFErick Forno
Erick Forno
DWDaniel J. Weiner
Daniel J. Weiner
JMJames Mullen
James Mullen
GSGregory Sawicki
Gregory Sawicki
GKGeoffrey Kurland
Geoffrey Kurland
JCJuan C. Celedón
Juan C. Celedón
Rationale: For unclear reasons, obese children with asthma have higher morbidity and reduced response to inhaled corticosteroids. Objectives: To assess whether childhood obesity is associated with airway dysanapsis (an incongruence between the growth of the lungs and the airways) and whether dysanapsis is associated with asthma morbidity. Methods: We examined the relationship between obesity and dysanapsis in six cohorts of children with and without asthma, as well as the relationship between dysanapsis and clinical outcomes in children with asthma. Adjusted odds ratios (ORs) were calculated for each cohort and in a combined analysis of all cohorts; longitudinal analyses were also performed for cohorts with available data. Hazard ratios (HRs) for clinical outcomes were calculated for children with asthma in the Childhood Asthma Management Program. Measurements and Main Results: Being overweight or obese was associated with dysanapsis in both the cross-sectional (OR, 1.95; 95% confidence interval [CI], 1.62–2.35 [for overweight/obese compared with normal weight children]) and the longitudinal (OR, 4.31; 95% CI, 2.99–6.22 [for children who were overweight/obese at all visits compared with normal weight children]) analyses. Dysanapsis was associated with greater lung volumes (FVC, vital capacity, and total lung capacity) and lesser flows (FEV1 and forced expiratory flow, midexpiratory phase), and with indicators of ventilation inhomogeneity and anisotropic lung and airway growth. Among overweight/obese children with asthma, dysanapsis was associated with severe disease exacerbations (HR, 1.95; 95% CI, 1.38–2.75) and use of systemic steroids (HR, 3.22; 95% CI, 2.02–5.14). Conclusions: Obesity is associated with airway dysanapsis in children. Dysanapsis is associated with increased morbidity among obese children with asthma and may partly explain their reduced response to inhaled corticosteroids.

1 March 2001 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
GKGary P. Kobinger
Gary P. Kobinger
DWDaniel J. Weiner
Daniel J. Weiner
QYQian-Chun Yu
Qian-Chun Yu
JWJames M. Wilson
James M. Wilson

26 September 2013 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
PQPhilip H. Quanjer
Philip H. Quanjer
DWDaniel J. Weiner
Daniel J. Weiner
JPJeffrey J. Pretto
Jeffrey J. Pretto
DBDanny J. Brazzale
Danny J. Brazzale
PBPiotr W Boros
Piotr W Boros
The aim of this study was to determine the added value of measuring the forced expiratory flow at 25–75% of forced vital capacity (FVC) (FEF25–75%) and flow when 75% of FVC has been exhaled (FEF75%) over and above the measurement of the forced expiratory volume in 1 s (FEV1), FVC and FEV1/FVC ratio.We used spirometric measurements of FEV1, FVC and FEF25–75%from 11 654 white males and 11 113 white females, aged 3–94 years, routinely tested in the pulmonary function laboratories of four tertiary hospitals. FEF75%was available in 8254 males and 7407 females. Predicted values and lower limits of normal, defined as the fifth percentile, were calculated for FEV1, FVC, FEV1/FVC ratio, FEF25–75%and FEF75%using prediction equations from the Global Lung Function Initiative.There was very little discordance in classifying test results. FEF25–75%and FEF75%were below the normal range in only 2.75% and 1.29% of cases, respectively, whereas FEV1, FVC and FEV1/FVC ratio were within normal limits. Airways obstruction went undetected by FEF25–75%in 2.9% of cases and by FEF75%in 12.3% of cases.Maximum mid-expiratory flow and flow towards the end of the forced expiratory manoeuvre do not contribute usefully to clinical decision making over and above information from FEV1, FVC and FEV1/FVC ratio.

1 October 2013 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
JDJane C. Davies
Jane C. Davies
HSHelen Sheridan
Helen Sheridan
NBNicholas Bell
Nicholas Bell
SCSteve Cunningham
Steve Cunningham
SDStephanie D Davis
Stephanie D Davis
FRFelix Ratjen
Felix Ratjen

1 February 1999 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RBRobert Bals
Robert Bals
DWDaniel J. Weiner
Daniel J. Weiner
JWJames M. Wilson
James M. Wilson